Financial reports
ARS
2024 FY
Annual report to shareholders
10 Apr 24
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
12 Apr 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
Current reports
8-K
Entry into a Material Definitive Agreement
27 Mar 24
8-K
Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results
28 Feb 24
8-K
Results of Operations and Financial Condition
8 Jan 24
8-K
Departure of Directors or Certain Officers
9 Nov 23
8-K
Castle Biosciences Reports Third Quarter 2023 Results
2 Nov 23
8-K
Castle Biosciences Reports Second Quarter 2023 Results
2 Aug 23
8-K
Regulation FD Disclosure
5 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
1 Jun 23
8-K
Castle Biosciences Reports First Quarter 2023 Results
3 May 23
8-K
Castle Biosciences Reports Fourth Quarter and Full-Year 2022 Results
28 Feb 23
Registration and prospectus
S-8
Registration of securities for employees
28 Feb 24
S-3
Shelf registration
28 Feb 24
S-8
Registration of securities for employees
4 Dec 23
S-8
Registration of securities for employees
28 Feb 23
S-8
Registration of securities for employees
28 Feb 23
S-3ASR
Automatic shelf registration
3 Jun 22
S-8
Registration of securities for employees
28 Feb 22
S-3ASR
Automatic shelf registration
14 Jan 22
S-8
Registration of securities for employees
11 Mar 21
424B5
Prospectus supplement for primary offering
16 Dec 20
Proxies
DEFA14A
Additional proxy soliciting materials
10 Apr 24
DEF 14A
Definitive proxy
10 Apr 24
DEFA14A
Additional proxy soliciting materials
15 May 23
DEFA14A
Additional proxy soliciting materials
12 Apr 23
DEF 14A
Definitive proxy
12 Apr 23
DEFA14A
Additional proxy soliciting materials
21 Apr 22
DEF 14A
Definitive proxy
21 Apr 22
DEFA14A
Additional proxy soliciting materials
13 May 21
DEFA14A
Additional proxy soliciting materials
27 Apr 21
DEF 14A
Definitive proxy
27 Apr 21
Other
EFFECT
Notice of effectiveness
17 Apr 24
EFFECT
Notice of effectiveness
25 Jun 20
CORRESP
Correspondence with SEC
22 Jun 20
CORRESP
Correspondence with SEC
22 Jun 20
UPLOAD
Letter from SEC
17 Jun 20
EFFECT
Notice of effectiveness
25 Jul 19
SEC STAFF
SEC staff action: Order
24 Jul 19
CERT
Certification of approval for exchange listing
23 Jul 19
CORRESP
Correspondence with SEC
23 Jul 19
CORRESP
Correspondence with SEC
23 Jul 19
Ownership
4
DEREK J MAETZOLD
25 Apr 24
4
DEREK J MAETZOLD
16 Apr 24
144
Notice of proposed sale of securities
12 Apr 24
4
DANIEL BRADBURY
10 Apr 24
4
DANIEL BRADBURY
8 Apr 24
4
DEREK J MAETZOLD
5 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
4
Rodney Cotton
28 Mar 24
3
Rodney Cotton
28 Mar 24
4
DEREK J MAETZOLD
22 Mar 24